
Australian tech entrepreneur Paul Conyngham used AI tools ChatGPT and AlphaFold to develop a personalized mRNA cancer vaccine for his dog Rosie after conventional treatments failed. By sequencing Rosie's tumor DNA with the University of New South Wales, he identified mutations and designed a targeted vaccine. Administered in December, the treatment reportedly halved the tumor size and improved Rosie's condition, highlighting AI's potential in veterinary personalized medicine.
Select a news story to see related coverage from other media outlets.